F i g u r e 1 . CT s c a n s h o wi n g a r i g h t f r o n t a l v e n t r i c u l a r s h u n t p l a c e d a s a n e me r g e n c y t r e a t me n t 
Introduction

Sarcoidosis is a multisystemic disease of unknown origin; it is characterized by an accumulation of non-caseating epithelioid granulomas (1)
CT scan showed acute hydrocephalus with a meningeal contrast-enhancement localized in the posterior cerebral F i g u r e 2 . Ma g n e t i c r e s o n a n c e i ma g i n g o f t h e c e n t r a l n e r v o u s s y s t e m, i n p o s t -g a d o l i n i u m a x i a l T 1 -we i g h t e d i ma g e ( a ) s h o wi n g g r a n u l o ma t o u s i n f i l t r a t i o n a l o n g t h e Vi r c h o w Ro b i n s p a c e s a n d i n ( b ) a n e x t e n s i v e b a s a l l e p t o me n i n g e a l i n f i l t r a t i o n , i n ( c ) a p o s t -g a d o l i n i u m s a g i t t a l T 1 -we i g h t e d i ma g e s h o wi n g e x t r a -a x i a l c o n t r a s t e n h a n c e me n t a l o n g t h e b a s e o f t h e b r a i n , p o s t e r i o r f o s s a a n d c e rv i c a l c a n a l . 
F i g u r e 4 . CT s c a n o f c o n t r o l a t t h e f o u r t h mo n t h s h o wi n g a c o mp l e t e r e g r e s s i o n o f t h e h y d r o c e p h a l u s wi t h o u t v a s c u l a r c o mp l i c a t i o n . T h e s u b a r a c h n o i d s p a c e i s c l e a r l y v i s i b l e .
At this stage, the general physical examination revealed bilateral cervical and submandibular lymphadenopathy of 1 cm diameter. Excisional biopsy of the left lateral cervical adenopathy showed non caseating epitheloid granuloma (Fig. 3) (Fig. 4) . According to his clinical status, the prednisone dose was progressively decreased after four weeks. Finally, the patient has an independent functional status after one year of clinical follow-up.
Discussion
Neurological manifestations of sarcoidosis are observed in approximately 5% of patients (2-4); these mainly consist of cranial and peripheral nerve lesions, with the most frequent manifestation being seventh nerve palsy (4). Other manifestations include optic neuritis, aseptic meningitis, hearing abnormalities, headache, vertigo, hypothalamic and pituitary dysfunction, mass-lesion effect, myopathy, seizure and psychiatric symptoms (3, 5). Hydrocephalus is a very uncommon finding. It results in fourth ventricular outflow obstruction or reduced absorption of the cerebrospinal fluid (6, 7). To date, there is only one reported case of hydrocephalus occurring in neurosarcoidosis as the first symptom (8).
Classically (4, 9) . (14) . Thus, MRI can prove positive in 65% of patients, but no neurodiagnostic tests alone are pathognomonic for neurosarcoidosis (15) (8) . In the case of failure, immunosuppressive agents and radiation therapy can be used (16) . The goal for this kind of treatment is to diminish the irreversible fibrosis that can develop as well as the tissue ischemia that might result from perivascular inflammation (9) .
MRI has been reported as the preferred imaging technique to evaluate neurosarcoidosis (10-13). T1-weighted images accurately depict hydrocephalus and spinal cord enlargement while T2-weighted and FLAIR slices exhibit increased signal intensity, especially in a periventricular distribution. Contrast administration can demonstrate leptomeningeal enhancement as well as parenchymal abnormalities and, occasionally cranial nerve lesions
In such cases of neurosarcoidosis, the outcome varies according to the neurological presentation (13) . Overall, the prognosis for neurosarcoidosis is good (8) ; 90% of the neurologic manifestations remit or improve with time, nevertheless, hydrocephalus has the worst long-term prognosis with a mortality rate of 75% (8, 13) 
